Activatable molecular probes for cancer imaging.

The development of highly sensitive and specific molecular probes for cancer imaging still remains a daunting challenge. Recently, interdisciplinary research at the interface of imaging sciences and bionanoconjugation chemistry has generated novel activatable imaging probes that can provide high-resolution imaging with ultra-low background signals. Activatable imaging probes are designed to amplify output imaging signals in response to specific biomolecular recognition or environmental changes in real time. This review introduces and highlights the unique design strategies and applications of various activatable imaging probes in cancer imaging.

[1]  A. Samad,et al.  Dendrimers: a class of polymers in the nanotechnology for the delivery of active pharmaceuticals. , 2009, Current pharmaceutical design.

[2]  Ick Chan Kwon,et al.  New Generation of Multifunctional Nanoparticles for Cancer Imaging and Therapy , 2009 .

[3]  J. Willson,et al.  Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Grütter,et al.  Caspases: key players in programmed cell death. , 2000, Current opinion in structural biology.

[5]  N O Reich,et al.  Nanometal surface energy transfer in optical rulers, breaking the FRET barrier. , 2005, Journal of the American Chemical Society.

[6]  U. Krull,et al.  Quantum dots as donors in fluorescence resonance energy transfer for the bioanalysis of nucleic acids, proteins, and other biological molecules , 2008, Analytical and bioanalytical chemistry.

[7]  Jianghong Rao,et al.  Quantum dot/bioluminescence resonance energy transfer based highly sensitive detection of proteases. , 2007, Angewandte Chemie.

[8]  Zeev Rosenzweig,et al.  Synthesis and application of quantum dots FRET-based protease sensors. , 2006, Journal of the American Chemical Society.

[9]  Sanjiv S Gambhir,et al.  Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. , 2006, Nano letters.

[10]  Sanjiv S Gambhir,et al.  Molecular imaging: the vision and opportunity for radiology in the future. , 2007, Radiology.

[11]  Yigong Shi,et al.  Molecular mechanisms of caspase regulation during apoptosis , 2004, Nature Reviews Molecular Cell Biology.

[12]  Jide Xu,et al.  Time gating improves sensitivity in energy transfer assays with terbium chelate/dark quencher oligonucleotide probes. , 2004, Journal of the American Chemical Society.

[13]  R. Weissleder,et al.  Enzyme-targeted fluorescent imaging probes on a multiple antigenic peptide core. , 2006, Journal of medicinal chemistry.

[14]  A. Libchaber,et al.  Single-mismatch detection using gold-quenched fluorescent oligonucleotides , 2001, Nature Biotechnology.

[15]  Weibo Cai,et al.  Nanoplatforms for targeted molecular imaging in living subjects. , 2007, Small.

[16]  Antony K Chen,et al.  In vivo imaging of cancer biomarkers using activatable molecular probes. , 2008, Cancer biomarkers : section A of Disease markers.

[17]  Igor L. Medintz,et al.  Self-assembled nanoscale biosensors based on quantum dot FRET donors , 2003, Nature materials.

[18]  Ralph Weissleder,et al.  In vivo molecular target assessment of matrix metalloproteinase inhibition , 2001, Nature Medicine.

[19]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[20]  R. Weissleder,et al.  In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response. , 2004, Arthritis and rheumatism.

[21]  Ick Chan Kwon,et al.  A near-infrared-fluorescence-quenched gold-nanoparticle imaging probe for in vivo drug screening and protease activity determination. , 2008, Angewandte Chemie.

[22]  Sanjiv S Gambhir,et al.  Self-illuminating quantum dot conjugates for in vivo imaging , 2006, Nature Biotechnology.

[23]  Ick Chan Kwon,et al.  Polymeric nanomedicine for cancer therapy , 2008 .

[24]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[25]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[26]  Kinneret Keren,et al.  Dynamic imaging of protease activity with fluorescently quenched activity-based probes , 2005, Nature chemical biology.

[27]  Roger Y Tsien,et al.  In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. , 2009, Integrative biology : quantitative biosciences from nano to macro.

[28]  Seulki Lee,et al.  Peptide-based probes for targeted molecular imaging. , 2010, Biochemistry.

[29]  C. Ahn,et al.  Polymeric nanoparticle-based activatable near-infrared nanosensor for protease determination in vivo. , 2009, Nano letters.

[30]  Miriam Scadeng,et al.  Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival , 2010, Proceedings of the National Academy of Sciences.

[31]  K. Bullok,et al.  Synthesis and characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. , 2005, Journal of medicinal chemistry.

[32]  Vasilis Ntziachristos,et al.  Inflammation in Atherosclerosis: Visualizing Matrix Metalloproteinase Action in Macrophages In Vivo , 2006, Circulation.

[33]  R. Weissleder,et al.  Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes. , 2002, Radiology.

[34]  R Weissleder,et al.  In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. , 2000, Cancer research.

[35]  Hisataka Kobayashi,et al.  In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green. , 2009, Cancer research.

[36]  Ralph Weissleder,et al.  Developing a peptide-based near-infrared molecular probe for protease sensing. , 2004, Bioconjugate chemistry.

[37]  L. Matrisian,et al.  Optical Imaging of Matrix Metalloproteinase-7 Activity in Vivo Using a Proteolytic Nanobeacon , 2008, Molecular imaging.

[38]  Elodie Boisselier,et al.  Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. , 2009, Chemical Society reviews.

[39]  Seulki Lee,et al.  Dual-Modality Probes for in Vivo Molecular Imaging , 2009, Molecular imaging.

[40]  Ick Chan Kwon,et al.  Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[41]  R. Weissleder,et al.  An azulene dimer as a near-infrared quencher. , 2002, Angewandte Chemie.

[42]  Tristan Barrett,et al.  Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes , 2009, Nature Medicine.

[43]  David Piwnica-Worms,et al.  An improved cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for apoptosis imaging. , 2009, Bioconjugate chemistry.

[44]  K. Schulze-Osthoff,et al.  New Approaches and Therapeutics Targeting Apoptosis in Disease , 2005, Pharmacological Reviews.

[45]  Roger Y Tsien,et al.  Tumor imaging by means of proteolytic activation of cell-penetrating peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Tae Gwan Park,et al.  Synthesis, characterization, and in vivo diagnostic applications of hyaluronic acid immobilized gold nanoprobes. , 2008, Biomaterials.

[47]  R Weissleder,et al.  Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging. , 1999, Bioconjugate chemistry.

[48]  Ammasi Periasamy,et al.  Fluorescence resonance energy transfer (FRET) microscopy imaging of live cell protein localizations , 2003, The Journal of cell biology.

[49]  S. Ito,et al.  Optimal labeling condition of antibodies available for immunofluorescence endoscopy. , 2006, The journal of medical investigation : JMI.

[50]  Jianghong Rao,et al.  Biosensing and imaging based on bioluminescence resonance energy transfer. , 2009, Current opinion in biotechnology.

[51]  Igor L. Medintz,et al.  Proteolytic activity monitored by fluorescence resonance energy transfer through quantum-dot–peptide conjugates , 2006, Nature materials.

[52]  R. Weissleder,et al.  High efficiency synthesis of a bioconjugatable near-infrared fluorochrome. , 2003, Bioconjugate chemistry.

[53]  J. Matthew Mauro,et al.  Long-term multiple color imaging of live cells using quantum dot bioconjugates , 2003, Nature Biotechnology.

[54]  David Piwnica-Worms,et al.  Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model , 2009, Proceedings of the National Academy of Sciences.

[55]  Matthew Bogyo,et al.  Activity based probes for proteases: applications to biomarker discovery, molecular imaging and drug screening. , 2007, Current pharmaceutical design.

[56]  Ick Chan Kwon,et al.  Dark quenched matrix metalloproteinase fluorogenic probe for imaging osteoarthritis development in vivo. , 2008, Bioconjugate chemistry.

[57]  Ick Chan Kwon,et al.  Activatable imaging probes with amplified fluorescent signals. , 2008, Chemical communications.

[58]  Igor L. Medintz,et al.  Quantum dot-based resonance energy transfer and its growing application in biology. , 2009, Physical chemistry chemical physics : PCCP.

[59]  Vasilis Ntziachristos,et al.  Shedding light onto live molecular targets , 2003, Nature Medicine.

[60]  Kwangmeyung Kim,et al.  Polymers for bioimaging , 2007 .

[61]  Georges von Degenfeld,et al.  Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. , 2007, Nature chemical biology.

[62]  J. Frangioni.  In vivo near-infrared fluorescence imaging. , 2003, Current opinion in chemical biology.

[63]  Matthew Bogyo,et al.  Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes , 2009, Nature Medicine.

[64]  R. Weissleder,et al.  In Vivo Imaging of HIV Protease Activity in Amplicon Vector-transduced Gliomas , 2004, Cancer Research.

[65]  Tristan Barrett,et al.  In vivo Diagnosis of Epidermal Growth Factor Receptor Expression using Molecular Imaging with a Cocktail of Optically Labeled Monoclonal Antibodies , 2007, Clinical Cancer Research.

[66]  Anna M Wu,et al.  Antibodies for Molecular Imaging of Cancer , 2008, Cancer journal.

[67]  Samuel Achilefu,et al.  Activatable molecular systems using homologous near-infrared fluorescent probes for monitoring enzyme activities in vitro, in cellulo, and in vivo. , 2009, Molecular pharmaceutics.

[68]  Igor L. Medintz,et al.  Sensing caspase 3 activity with quantum dot-fluorescent protein assemblies. , 2009, Journal of the American Chemical Society.

[69]  R. M. Cook,et al.  Intramolecular dimers: a new design strategy for fluorescence-quenched probes. , 2003, Chemistry.